Mabpharm Limited

SEHK:2181 주식 보고서

시가총액: HK$1.5b

Mabpharm 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Hao Wang

최고 경영자

CN¥5.6m

총 보상

CEO 급여 비율19.1%
CEO 임기6.3yrs
CEO 소유권n/a
경영진 평균 재임 기간6.3yrs
이사회 평균 재임 기간4.1yrs

최근 관리 업데이트

Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

Jun 14
Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

Recent updates

Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

Jun 14
Shareholders May Be A Bit More Conservative With Mabpharm Limited's (HKG:2181) CEO Compensation For Now

More Unpleasant Surprises Could Be In Store For Mabpharm Limited's (HKG:2181) Shares After Tumbling 41%

Jan 24
More Unpleasant Surprises Could Be In Store For Mabpharm Limited's (HKG:2181) Shares After Tumbling 41%

Mabpharm (HKG:2181) Is Making Moderate Use Of Debt

Oct 20
Mabpharm (HKG:2181) Is Making Moderate Use Of Debt

Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Jan 18
Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Oct 07
Here's Why We're Watching Mabpharm's (HKG:2181) Cash Burn Situation

Here's Why We're Not Too Worried About Mabpharm's (HKG:2181) Cash Burn Situation

Apr 28
Here's Why We're Not Too Worried About Mabpharm's (HKG:2181) Cash Burn Situation

Did You Miss Mabpharm's (HKG:2181) 14% Share Price Gain?

Mar 03
Did You Miss Mabpharm's (HKG:2181) 14% Share Price Gain?

We're Not Very Worried About Mabpharm's (HKG:2181) Cash Burn Rate

Jan 27
We're Not Very Worried About Mabpharm's (HKG:2181) Cash Burn Rate

Do Insiders Own Lots Of Shares In Mabpharm Limited (HKG:2181)?

Dec 09
Do Insiders Own Lots Of Shares In Mabpharm Limited (HKG:2181)?

CEO 보상 분석

Hao Wang 의 보수는 Mabpharm 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-CN¥207m

Mar 31 2024n/an/a

-CN¥208m

Dec 31 2023CN¥6mCN¥1m

-CN¥209m

Sep 30 2023n/an/a

-CN¥202m

Jun 30 2023n/an/a

-CN¥194m

Mar 31 2023n/an/a

-CN¥202m

Dec 31 2022CN¥3mCN¥1m

-CN¥211m

Sep 30 2022n/an/a

-CN¥237m

Jun 30 2022n/an/a

-CN¥263m

Mar 31 2022n/an/a

-CN¥278m

Dec 31 2021CN¥5mCN¥1m

-CN¥292m

보상 대 시장: Hao 의 총 보상 ($USD 772.07K )은 Hong Kong 시장( $USD 347.84K ).

보상과 수익: 회사가 수익성이 없는 동안 Hao 의 보상이 증가했습니다.

CEO

Hao Wang (55 yo)

6.3yrs

테뉴어

CN¥5,596,000

보상

Dr. Hao Wang serves as Chief Executive Officer and Executive Director at Mabpharm Limited since October 28, 2020 and July 20, 2018 respectively and also serves as Chief Scientist since August 2018. Dr. Wan...

리더십 팀

이름위치테뉴어보상소유권
Hao Wang
Chief Scientist6.3yrsCN¥5.60m데이터 없음
Jing Tao
VP & Executive Directorno dataCN¥1.54m데이터 없음
Sheng Hou
VP & Executive Directorless than a yearCN¥70.00k데이터 없음
Weizhu Qian
VP & Executive Directorless than a yearCN¥445.00k데이터 없음
Yunfeng Li
VP, Joint Company Secretary & Executive Director6.3yrsCN¥1.58m데이터 없음
Jing Li
Vice President6.3yrsCN¥1.40m데이터 없음
Ho Yin Tsang
Joint Company Secretaryno data데이터 없음데이터 없음

6.3yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 관리: 2181 의 관리팀은 노련하고 경험 (평균 재직 기간 6.3 년)입니다.

이사회 구성원

이름위치테뉴어보상소유권
Hao Wang
Chief Scientist6.3yrsCN¥5.60m데이터 없음
Jing Tao
VP & Executive Director4.1yrsCN¥1.54m데이터 없음
Sheng Hou
VP & Executive Directorless than a yearCN¥70.00k데이터 없음
Weizhu Qian
VP & Executive Directorless than a yearCN¥445.00k데이터 없음
Yunfeng Li
VP, Joint Company Secretary & Executive Director6.3yrsCN¥1.58m데이터 없음
Shuge Jiao
Non-Executive Chairman6.3yrs데이터 없음데이터 없음
Liangzhong Guo
Independent Non-Executive Director6.3yrsCN¥108.00k데이터 없음
Yanyun Zhang
Independent Non-Executive Director6.3yrsCN¥108.00k데이터 없음
Louis Ho Ming
Independent Non-Executive Director2.4yrsCN¥108.00k데이터 없음
Jialin Cen
Non-Executive Directorless than a year데이터 없음데이터 없음
Qian Tao
Independent Non-Executive Directorless than a year데이터 없음데이터 없음

4.1yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 이사회: 2181 의 이사회는 경험(평균 재직 기간 4.1 년)으로 간주됩니다.